Aia Group LTD Medpace Holdings, Inc. Transaction History

Aia Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$227.52 - $312.68 $64,843 - $89,113	-285 Reduced 13.48%	1,829 $560,000
Q3 2023 Nov 01, 2023	SELL	$233.98 - $281.67 $744,758 - $896,555	-3,183 Reduced 60.09%	2,114 $511,000
Q2 2023 Jul 28, 2023	BUY	$187.26 - $240.17 $991,916 - $1.27 Million	5,297 New	5,297 $1.27 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

Stay updated on Aia Group LTD with notifications on news.